The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
Dubai / WAM
Dr Abdul Rahman bin Mohammad bin Nasser Al Owais, Minister of Health and Prevention, issued a Ministerial Decree No. 130 of 2019 on reduction of price of 410 similar drugs, in line with government’s directives to reduce prices of services, and based on ministry’s keenness to provide medicines at competitive prices.
Accordingly, the Ministry of Health and Prevention (MoHAP), held a meeting with the concerned companies to coordinate joint efforts to support patients and provide pharmaceutical services of high standards and quality at competitive prices.
The list of similar medicines covered by this resolution includes a wide range of medications for treating cardiovascular diseases, hypertension, lipid-lowering and angina, which are common chronic diseases in region, with a reduction rate ranging from 2 to 77%, of which 183 varieties locally manufactured and 227 regionally and globally.
It also aimed to foster the strategic partnership between MoHAP and the private pharmaceutical companies operating in the country and to lay out the foundations for the prior coordination for the implementation of this initiative. The initiative also provides wider options for patients to reduce the leakage of counterfeit medicines through online pharmacies and other unreliable sources.
MoHAP has officially addressed the concerned companies to take the necessary steps towards reducing prices within a specific time frame for implementation on September 15.